(Q52553555)

English

Risk factors for recurrent cholangitis after initial hepatolithiasis treatment.

scientific article published in April 2004

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15087697

retrieved

3 May 2018

reference URL

http://europepmc.org/abstract/MED/15087697

title

Risk factors for recurrent cholangitis after initial hepatolithiasis treatment. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15087697

retrieved

3 May 2018

reference URL

http://europepmc.org/abstract/MED/15087697

main subject

ascending cholangitis

0 references

author

Jae Hee Cheon

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15087697

retrieved

3 May 2018

reference URL

http://europepmc.org/abstract/MED/15087697

author name string

Jin-Hyeok Hwang

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15087697

retrieved

3 May 2018

reference URL

http://europepmc.org/abstract/MED/15087697

Yong Bum Yoon

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15087697

retrieved

3 May 2018

reference URL

http://europepmc.org/abstract/MED/15087697

Yong-Tae Kim

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15087697

retrieved

3 May 2018

reference URL

http://europepmc.org/abstract/MED/15087697

Ji Bong Jeong

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15087697

retrieved

3 May 2018

reference URL

http://europepmc.org/abstract/MED/15087697

publication date

1 April 2004

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15087697

retrieved

3 May 2018

reference URL

http://europepmc.org/abstract/MED/15087697

published in

Journal of Clinical Gastroenterology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15087697

retrieved

3 May 2018

reference URL

http://europepmc.org/abstract/MED/15087697

volume

38

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15087697

retrieved

3 May 2018

reference URL

http://europepmc.org/abstract/MED/15087697

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15087697

retrieved

3 May 2018

reference URL

http://europepmc.org/abstract/MED/15087697

page(s)

364-367

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15087697

retrieved

3 May 2018

reference URL

http://europepmc.org/abstract/MED/15087697

Identifiers

DOI

10.1097/00004836-200404000-00012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15087697

retrieved

3 May 2018

reference URL

http://europepmc.org/abstract/MED/15087697

PubMed publication ID

15087697

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15087697

retrieved

3 May 2018

reference URL

http://europepmc.org/abstract/MED/15087697

(Q52553555)

Risk factors for recurrent cholangitis after initial hepatolithiasis treatment.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)